Skip to main content

Depressive Disorders: Prevalence, Costs, and Theories

  • Chapter
  • First Online:
Herbal Medicine in Depression

Abstract

The estimated global cost of mental health conditions, including depressive disorders, was US$2.5 trillion in 2010. According to the World Health Organization (WHO), more than 350 million people of all ages suffer from depression, 10–40 % of them not improving their condition with the current drug therapies, thus contributing to the increased burden of mental disorders. Indeed, prognostics are not encouraging since it is predicted that unipolar depressive disorders will be the first cause of disability-adjusted life years (DALYs) by the year 2030. For these reasons, it is urgent to find new antidepressant drugs that act on other targets rather than the conventional one (monoamine transmission). Having this in mind, this chapter provides a critical review of the theories available to explain the pathogenesis of depressive disorders, namely, those focusing on disturbances of monoamine, glutamate and GABA transmission, changes in the hypothalamic-pituitary-adrenal (HPA) axis, neuroinflammation, neurogenesis and neurotrophic factors, glial pathology, epigenetic mechanisms, and disturbance of the circadian rhythm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ağargün MY, Cilli AS, Kara H, Tarhan N, Kincir F, Oz H. Repetitive and frightening dreams and suicidal behavior in patients with major depression. Compr Psychiatry. 1998;39(4):198–202.

    Article  PubMed  Google Scholar 

  • Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607–11.

    Article  CAS  PubMed  Google Scholar 

  • Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:369–88.

    Article  PubMed  PubMed Central  Google Scholar 

  • Altman J. Autoradiographic and histological studies of postnatal neurogenesis. III. Dating the time of production and onset of differentiation of cerebellar microneurons in rats. J Comp Neurol. 1969;136(3):269–93.

    Article  CAS  PubMed  Google Scholar 

  • Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124(3):319–35.

    Article  CAS  PubMed  Google Scholar 

  • Altman J, Das GD. Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J Comp Neurol. 1966;126(3):337–89.

    Article  CAS  PubMed  Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  • Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology. 2011;36(3):415–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004;77(6):858–66.

    Article  CAS  PubMed  Google Scholar 

  • Ataka T, Gu JG. Relationship between tonic inhibitory currents and phasic inhibitory activity in the spinal cord lamina II region of adult mice. Mol Pain. 2006;2:36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305–13.

    Article  CAS  PubMed  Google Scholar 

  • Bachis A, Mallei A, Cruz MI, Wellstein A, Mocchetti I. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology. 2008;55(7):1114–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baldessarini RJ. Biogenic amines and behavior. Annu Rev Med. 1972;23(5):343–54.

    Article  CAS  PubMed  Google Scholar 

  • Barden N. Implication of the hypothalamic–pituitary–adrenal axis in the physiopathology of depression. J Psychiatry Neurosci. 2004;29(3):185–93.

    PubMed  PubMed Central  Google Scholar 

  • Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. MiR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science. 2010;329(5998):1537–41.

    Article  CAS  PubMed  Google Scholar 

  • Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord. 2005;7(5):449–55.

    Article  CAS  PubMed  Google Scholar 

  • Beaurepaire R. Questions raised by the cytokine hypothesis of depression. Brain Behav Immun. 2002;16:610–7.

    Article  PubMed  CAS  Google Scholar 

  • Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351–4.

    Article  CAS  PubMed  Google Scholar 

  • Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry. 2011;16(6):634–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311(5762):864–8.

    Article  CAS  PubMed  Google Scholar 

  • Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum; 2011.

    Google Scholar 

  • Bouwer C, Claassen J, Dinan TG, Nemeroff CB. Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. Depress Anxiety. 2000;12(1):44–50.

    Article  CAS  PubMed  Google Scholar 

  • Bowley MP, Drevets WC, Ongür D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 2002;52(5):404–12.

    Article  PubMed  Google Scholar 

  • Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157(1):115–8.

    Article  CAS  PubMed  Google Scholar 

  • Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience. 1999;89(4):999–1002.

    Article  CAS  PubMed  Google Scholar 

  • Büttner N, Johnsen SA, Kügler S, Vogel T. Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex. Proc Natl Acad Sci U S A. 2010;107(15):7042–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Calabrese F, Guidotti G, Racagni G, Riva MA. Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol Aging. 2013;34(12):2768–76.

    Article  CAS  PubMed  Google Scholar 

  • Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8:430.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cardinali DP, Srinivasan V, Brzezinski A, Brown GM. Melatonin and its analogs in insomnia and depression. J Pineal Res. 2012;52(4):365–75.

    Article  CAS  PubMed  Google Scholar 

  • Carlsson A, Lindqvist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science. 1958;127(3296):471.

    Article  CAS  PubMed  Google Scholar 

  • Carroll BJ, Martin FIR, Davies B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J. 1968;3:285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981;38(1):15–22.

    Article  CAS  PubMed  Google Scholar 

  • Chan JP, Unger TJ, Byrnes J, Rios M. Examination of behavioral deficits triggered by targeting BDNF in fetal or postnatal brains of mice. Neuroscience. 2006;142:49–58.

    Article  CAS  PubMed  Google Scholar 

  • Chana G, Landau S, Beasley C, Everall IP, Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry. 2003;53(12):1086–98.

    Article  PubMed  Google Scholar 

  • Chessin M, Dubnick B, Kramer ER, Scott CC. Modifications of pharmacology of reserpine and serotonin by iproniazid. J Pharmacol Exp Ther. 1957;119(4):453–60.

    CAS  PubMed  Google Scholar 

  • Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney Jr WE, Akil H, Watson SJ, Jones EG. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A. 2005;102(43):15653–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chourbaji S, Hellweg R, Brandis D, Zörner B, Zacher C, Lang UE, Henn FA, Hörtnagl H, Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Mol Brain Res. 2004;121(1-2):28–36.

    Article  CAS  PubMed  Google Scholar 

  • Cinini SM, Barnabe GF, Galvão-Coelho N, de Medeiros MA, Perez-Mendes P, Sousa MB, Covolan L, Mello LE. Social isolation disrupts hippocampal neurogenesis in young non-human primates. Front Neurosci. 2014;8:45.

    Article  PubMed  PubMed Central  Google Scholar 

  • Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113(504):1237–64.

    Article  CAS  PubMed  Google Scholar 

  • Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 2001;58(6):545–53.

    Article  CAS  PubMed  Google Scholar 

  • Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12(4):386–94.

    Article  PubMed  Google Scholar 

  • Cotter D, Hudson L, Landau S. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord. 2005;7(4):358–69.

    Article  PubMed  Google Scholar 

  • Covington HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ. Antidepressant actions of histone deacetylase inhibitors. J Neurosci. 2009;29(37):11451–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Craddock N, Jones L, Jones IR, Kirov G, Green EK, Grozeva D, Moskvina V, Nikolov I, Hamshere ML, Vukcevic D, Caesar S, Gordon-Smith K, Fraser C, Russell E, Norton N, Breen G, St Clair D, Collier DA, Young AH, Ferrier IN, Farmer A, McGuffin P, Holmans PA, Wellcome Trust Case Control Consortium (WTCCC), Donnelly P, Owen MJ, O'Donovan MC. Strong genetic evidence for a selective influence of GABA(A) receptors on a component of the bipolar disorder phenotype. Mol Psychiatry. 2010;15(2):146–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Czéh B, Welt T, Fischer AK, Erhardt A, Schmitt W, Müller MB, Toschi N, Fuchs E, Keck ME. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry. 2002;52(11):1057–65.

    Article  PubMed  Google Scholar 

  • Danilenko KV, Ivanova IA. Dawn simulation vs. bright light in seasonal affective disorder: Treatment effects and subjective preference. J Affect Disord. 2015;180:87–9.

    Article  CAS  PubMed  Google Scholar 

  • Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O’Brien JT. Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J Neurol Neurosurg Psychiatry. 2002;73(5):556–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de Bellis MD, Gold PW, Geracioti Jr TD, Listwak SJ, Kling MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry. 1993;150(4):656–7.

    Article  PubMed  Google Scholar 

  • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9(8):628–42.

    PubMed  Google Scholar 

  • Dias BG, Banerjee SB, Duman RS, Vaidya VA. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology. 2003;45:553–63.

    Article  CAS  PubMed  Google Scholar 

  • Dias BG, Maddox SA, Klengel T, Ressler KJ. Epigenetic mechanisms underlying learning and the inheritance of learned behaviors. Trends Neurosci. 2015;38(2):96–107.

    Google Scholar 

  • Drew MR, Hen R. Adult hippocampal neurogenesis as target for the treatment of depression. CNS Neurol Disord Drug Targets. 2007;6(3):205–18.

    Article  CAS  PubMed  Google Scholar 

  • Eisch AJ, Bolaños CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry. 2003;54(10):994–1005.

    Article  CAS  PubMed  Google Scholar 

  • Elliott E, Ezra-Nevo G, Regev L, Neufeld-Cohen A, Chen A. Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nat Neurosci. 2010;13(11):1351–3.

    Article  CAS  PubMed  Google Scholar 

  • Emrich HM, Zerssen DV, Kissling W, Möller H-J, Windorfer A. Effect of sodium valproate on mania: the GABA-hypothesis of affective disorders. Arch Psychiatry Neurol Sci. 1980;229(1):1–16.

    CAS  Google Scholar 

  • Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313–7.

    Article  CAS  PubMed  Google Scholar 

  • Ernst C, Nagy C, Kim S, Yang JP, Deng X, Hellstrom IC, Choi KH, Gershenfeld H, Meaney MJ, Turecki G. Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers. Biol Psychiatry. 2011;70(4):312–9.

    Article  CAS  PubMed  Google Scholar 

  • Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry. 2012;169(10):1065–72.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gao J, Wang WY, Mao YW, Gräff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466(7310):1105–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerner RH, Hare TA. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry. 1981;138(8):1098–101.

    Article  CAS  PubMed  Google Scholar 

  • Gillin JC, Duncan W, Pettigrew KD, Frankel BL, Snyder F. Successful separation of depressed, normal and insomniac subjects by EEG sleep data. Arch Gen Psychiatry. 1979;36(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  • Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.

    Article  PubMed Central  Google Scholar 

  • Goel N, Innala L, Viau V. Sex differences in serotonin (5-HT) 1A receptor regulation of HPA axis and dorsal raphe responses to acute restraint. Psychoneuroendocrinology. 2014;40:232–41.

    Article  CAS  PubMed  Google Scholar 

  • Gould E, Woolley CS, McEwen BS. Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J Comp Neurol. 1991;313(3):479–85.

    Article  CAS  PubMed  Google Scholar 

  • Gould E, Cameron HA, Daniels DC, Woolley CS, McEwen BS. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci. 1992;12(9):3642–50.

    CAS  PubMed  Google Scholar 

  • Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci U S A. 2006;103(35):13208–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greenberg PE, Fournier A-A, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–62.

    Article  PubMed  Google Scholar 

  • Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007;12:1079–88.

    Article  CAS  PubMed  Google Scholar 

  • Grunbaum-Novak N, Taler M, Gil-Ad I, Weizman A, Cohen H, Weizman R. Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition. Eur Neuropsychopharmacol. 2008;18(6):431–8.

    Article  CAS  PubMed  Google Scholar 

  • Gu B, Lee MG. Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells. Cell Biosci. 2013;3(1):39.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Guan Z, Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 2006;20(1):64–71.

    Article  CAS  PubMed  Google Scholar 

  • Gwinn RP, Kondratyev A, Gale K. Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures. Neuroscience. 2002;114(2):403–9.

    Article  CAS  PubMed  Google Scholar 

  • Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry. 2004;55(6):563–9.

    Article  PubMed  Google Scholar 

  • Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. 2007;62(11):1310–6.

    Article  CAS  PubMed  Google Scholar 

  • Hedrich CM, Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med. 2011;17(12):714–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 2005;6:877–88.

    Article  CAS  PubMed  Google Scholar 

  • Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry. 1987;22:228–34.

    Article  CAS  PubMed  Google Scholar 

  • Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience. 1999;91(4):1247–55.

    Article  CAS  PubMed  Google Scholar 

  • Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990–2003. J Ment Health Policy Econ. 2006;9(1):3–13.

    PubMed  Google Scholar 

  • Hu TW, He Y, Zhang M, Chen N. Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol. 2007;42(2):110–6.

    Article  PubMed  Google Scholar 

  • Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang S, Litt M, Felsenfeld G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev. 2005;19(16):1885–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ. Electroencephalographic sleep in mania. Arch Gen Psychiatry. 1988;45(3):267–73.

    Article  CAS  PubMed  Google Scholar 

  • Hudson JI, Lipinski JF, Keck Jr PE, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ. Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry. 1992;49(5):378–83.

    Article  CAS  PubMed  Google Scholar 

  • Hunter RG. Epigenetic effects of stress and corticosteroids in the brain. Front Cell Neurosci. 2012;6:article 18.

    Google Scholar 

  • Hurley LL, Tizabi Y. Neuroinflammation, neurodegeneration, and depression. Neurotox Res. 2013;23:131–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hyland NP, Cryan JF. A gut feeling about GABA: focus on GABA(B) receptors. Front Pharmacol. 2010;1:124.

    Article  PubMed  PubMed Central  Google Scholar 

  • Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, Mosovich S, Farkouh ME. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med. 2013;126(11):1017.e11–18.

    Article  CAS  Google Scholar 

  • Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000;5:262–9.

    Article  CAS  PubMed  Google Scholar 

  • Jernajczyk W. Latency of eye movement and other REM sleep parameters in bipolar depression. Biol Psychiatry. 1986;21(5-6):465–72.

    Article  CAS  PubMed  Google Scholar 

  • Juruena MF, Cleare AJ, Bauer ME, Pariente CM. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatr. 2003;15:354–67.

    Article  PubMed  Google Scholar 

  • Juruena MF, Cleare AJ, Pariante CM. The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr. 2004;26(3):189–201.

    Article  PubMed  Google Scholar 

  • Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science. 1977;197(4308):1092–4.

    Article  CAS  PubMed  Google Scholar 

  • Kee N, Teixeira CM, Wang AH, Frankland PW. Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat Neurosci. 2007;10(3):355–62.

    Article  CAS  PubMed  Google Scholar 

  • Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, Ffrench-Mullen J, Turecki G. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry. 2009;14(2):175–89.

    Article  CAS  PubMed  Google Scholar 

  • Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci. 2012;13:325–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Krishnan KRR, Rayasam K, Reed DR, Smith M, Chappell P, Saunders WB, Ritchie JC, Carroll BJ, Nemeroff CB. The corticotropin releasing factor stimulation test in patients with major depression: Relationship to dexamethasone suppression test results. Depression. 1993;1(3):133–6.

    Article  Google Scholar 

  • Lapchak PA, Araujo DM, Beck KD, Finch CE, Johnson SA, Hefti F. BDNF and trkB mRNA expression in the hippocampal formation of aging rats. Neurobiol Aging. 1993;14(2):121–6.

    Article  CAS  PubMed  Google Scholar 

  • Lapin IP, Oxenkrug GF. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet. 1969;1(7586):132–6.

    Article  CAS  PubMed  Google Scholar 

  • Lauer CJ, Wiegand M, Krieg JC. All-night electroencephalographic sleep and cranial computed tomography in depression. A study of unipolar and bipolar patients. Eur Arch Psychiatry Clin Neurosci. 1992;242(2-3):59–68.

    Article  CAS  PubMed  Google Scholar 

  • Lavergne F, Jay TM. A new strategy for antidepressant prescription. Front Neurosci. 2010;4:192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levine J, Cholestoy A, Zimmerman J. Possible antidepressant effect of minocycline. Am J Psychiatry. 1996;153(4):582.

    CAS  PubMed  Google Scholar 

  • Loomer HP, Saunders IC, Kline NS. A clinical and pharmacodynamics evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc. 1958;8:129–41.

    Google Scholar 

  • López-Muñoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563–86.

    Article  PubMed  Google Scholar 

  • Lund C, Myer L, Stein DJ, Williams DR, Flisher AJ. Mental illness and lost income among adult South Africans. Soc Psychiatry Psychiatr Epidemiol. 2013;48(5):845–51.

    Article  PubMed  PubMed Central  Google Scholar 

  • Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16(4):383–406.

    Google Scholar 

  • Machado, M., Lopera, M.M., Diaz-Rojas, J., Jaramillo, L.E., Einarson, T.R., The Universidad Nacional de Colombia Pharmacoeconomics Group. Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia. Rev Panam Salud Publica. 2008;24(4):233–9.

    Google Scholar 

  • Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress induced anxiety. Cytokine. 1998a;10:313–8.

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand. 1998b;97(4):302–8.

    Article  CAS  PubMed  Google Scholar 

  • Maguire J. Stress-induced plasticity of GABAergic inhibition. Front Cell Neurosci. 2014;8:157.

    Google Scholar 

  • Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology. 2003;28(9):1562–71.

    Article  CAS  PubMed  Google Scholar 

  • Manicavasagar V. A review of depression diagnosis and management. Melbourne, VIC: The Australian Psychological Society; 2012.

    Google Scholar 

  • Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, Invernizzi G. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology. 1998;37(3):124–9.

    Article  CAS  PubMed  Google Scholar 

  • McCarthy DJ, Alexander R, Smith MA, Pathak S, Kanes S, Lee CM, Sanacora G. Glutamate-based depression GBD. Med Hypotheses. 2012;78(5):675–81.

    Article  CAS  PubMed  Google Scholar 

  • McLeod H, Rothberg A, Pels L, Eekhout S, Mubangizi DB, Fish T. The costing of the proposed chronic disease list benefits in South African medical schemes in 2001. Cape Town: Centre for Actuarial Research, University of Cape Town; 2002.

    Google Scholar 

  • McQuade R, Young AH. Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br J Psychiatry. 2000;177:390–5.

    Article  CAS  PubMed  Google Scholar 

  • McQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci. 2001;115:1145–53.

    Article  Google Scholar 

  • Mehl RC, O’Brien LM, Jones JH, Dreisbach JK, Mervis CB, Gozal D. Correlates of sleep and pediatric bipolar disorder. Sleep. 2006;29(2):193–7.

    PubMed  Google Scholar 

  • Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA, Rajkowska G. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry. 2000;48(8):861–73.

    Article  CAS  PubMed  Google Scholar 

  • Miguel-Hidalgo JJ, Waltzer R, Whittom AA, Austin MC, Rajkowska G, Stockmeier CA. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J Affect Disord. 2010;127(1-3):230–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miró X, Pérez-Torres S, Artigas F, Puigdomènech P, Palacios JM, Mengod G. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology. 2002;43:1148–57.

    Article  PubMed  Google Scholar 

  • Møldrup C, Oestergaard S. Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological interventions: a systematic review of reviews. Public Health. 2011;125:357–67.

    Article  PubMed  Google Scholar 

  • Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry. 2007;61(2):187–97.

    Article  CAS  PubMed  Google Scholar 

  • Mulinari S. Monoamine theories of depression: historical impact on biomedical research. J Hist Neurosci. 2012;21:366–92.

    Article  PubMed  Google Scholar 

  • Murphy DL, Garrick NA, Tamarkin L, Taylor PL, Markey SP. Effects of antidepressants and other psychotropic drugs on melatonin release and pineal gland function. J Neural Transm Suppl. 1986;21:291–309.

    CAS  PubMed  Google Scholar 

  • Nemeroff CB, Bissette G, Akil H, Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotrophin-releasing factor, beta-endorphin and somatostatin. Br J Psychiatry. 1991;158:59–63.

    Article  CAS  PubMed  Google Scholar 

  • Nestler EJ, Peña CJ, Kundakovic M, Mitchell A, Akbarian S. Epigenetic basis of mental illness. Neuroscientist. 2015. doi:10.1177/1073858415608147.

    PubMed  Google Scholar 

  • Newport DJ, Heim C, Owens MJ, Ritchie JC, Ramsey CH, Bonsall R, Miller AH, Nemeroff CB. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis. Neuropsychopharmacology. 2003;28(3):569–76.

    Article  CAS  PubMed  Google Scholar 

  • Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15(11):7539–47.

    CAS  PubMed  Google Scholar 

  • Niehrs C, Schäfer A. Active DNA demethylation by Gadd45 and DNA repair. Trends Cell Biol. 2012;22(4):220–7.

    Article  CAS  PubMed  Google Scholar 

  • Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA. Adaptive changes in the N-methyl-d-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther. 1993;265(3):1380–6.

    CAS  PubMed  Google Scholar 

  • Olesen J, Gustavsson A, Svensson M, Wittchen H-U, Jönsson B, on behalf of the CDBE2010 study group and the European Brain Council. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155–62.

    Article  CAS  PubMed  Google Scholar 

  • Ongür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ozbolt LB, Nemeroff CB. Chapter 2: HPA axis modulation in the treatment of mood disorders. In: Schoepf D, editor. Psychiatric disorders – new frontiers in affective disorders. Morn Hill: InTech; 2013.

    Google Scholar 

  • Pae CU, Marks DM, Han C, Patkar AA. Does minocycline have antidepressant effect? Biomed Pharmacother. 2008;62(5):308–11.

    Article  CAS  PubMed  Google Scholar 

  • Papp M, Moryl E. Similar effects of chronic treatment with imipramine and the NMDA antagonists CGP 37849 and MK-801 in a chronic mild stress model of depression in rats. Eur J Pharmacol. 1993;3(3):348–9.

    Google Scholar 

  • Papp M, Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur J Pharmacol. 1994;263(1-2):1–7.

    Article  CAS  PubMed  Google Scholar 

  • Park H, Poo M-m. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14:7–23.

    Article  CAS  PubMed  Google Scholar 

  • Parker G, McCraw S, Hadzi-Pavlovic D, Fletcher K. Costs of the principal mood disorders: a study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders. J Affect Disord. 2013;149(1-3):46–55.

    Article  PubMed  Google Scholar 

  • Paul IA, Layer RT, Skolnick P, Nowak G. Adaptation of the N-methyl-d-aspartate receptor complex in rat front cortex following chronic treatment with electroconvulsive shock or imipramine. J Pharmacol Exp Ther. 1993;247(3):305–12.

    CAS  Google Scholar 

  • Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther. 1994;269(1):95–102.

    CAS  PubMed  Google Scholar 

  • Petrik D, Lagace D, Eisch AJ. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology. 2012;62(1):21–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petty F. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin Chem. 1994;40(2):296–302.

    CAS  PubMed  Google Scholar 

  • Petty F, Schiesser MA. Plasma GABA in affective illness. A preliminary investigation. J Affect Disord. 1981;3(4):339–43.

    Article  CAS  PubMed  Google Scholar 

  • Pharm K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci. 2003;17:879–86.

    Article  Google Scholar 

  • Popper CW. Mood disorders in youth: exercise, light therapy, and pharmacologic complementary and integrative approaches. Child Adolesc Psychiatr Clin N Am. 2013;22(3):403–41.

    Article  PubMed  Google Scholar 

  • Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007;6(3):219–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45(9):1085–98.

    Article  CAS  PubMed  Google Scholar 

  • Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 2001;49(9):741–52.

    Article  CAS  PubMed  Google Scholar 

  • Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology. 2007;32(2):471–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rastad C, Ulfberg J, Lindberg P. Improvement in fatigue, sleepiness, and health-related quality of life with bright light treatment in persons with seasonal affective disorder and subsyndromal SAD. Depress Res Treat. 2011;2011:543906.

    PubMed  PubMed Central  Google Scholar 

  • Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58(9):700–4.

    Article  CAS  PubMed  Google Scholar 

  • Roth TL, Sweatt JD. Epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development. J Child Psychol Psychiatry. 2011;52(4):398–408.

    Article  PubMed  PubMed Central  Google Scholar 

  • Roy A, Dejong J, Ferraro T. CSF GABA in depressed patients and normal controls. Psychol Med. 1991;21(3):613–8.

    Article  CAS  PubMed  Google Scholar 

  • Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castrén E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci. 2003;23(1):349–57.

    CAS  PubMed  Google Scholar 

  • Salgado-Delgado R, Osorio AT, Saderi N, Escobar C. Disruption of circadian rhythms: a crucial factor in the etiology of depression. Depress Res Treat. 2011;2011:839743.

    PubMed  PubMed Central  Google Scholar 

  • Sanacora G, Mason GF, Rothman DL, Berman RM, Charney DS, Krystal JH. ECT effects on cortical GABA levels as determined by 1H-MRS. Scientific abstracts from the 37th annual meeting of the American College of Neuropsychopharmacology. San Juan: American College of Neuropsychopharmacology; 1998. p. 200.

    Google Scholar 

  • Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56(11):1043–7.

    Article  CAS  PubMed  Google Scholar 

  • Sanacora G, Mason GF, Rothman DL, Berman RM, Zimolo Z, Krystal JH. Cortical GABA concentrations are increased in depressed patients following treatment with selective serotonin reuptake inhibitors. Scientific abstracts from the 39th annual meeting of the American College of Neuropsychopharmacology. San Juan: American College of Neuropsychopharmacology; 2000. p. 200.

    Google Scholar 

  • Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanai N, Nguyen T, Ihrie RA, Mirzadeh Z, Tsai HH, Wong M, Gupta N, Berger MS, Huang E, Garcia-Verdugo JM, Rowitch DH, Alvarez-Buylla A. Corridors of migrating neurons in the human brain and their decline during infancy. Nature. 2011;478(7369):382–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805–9.

    Article  CAS  PubMed  Google Scholar 

  • Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:201–17.

    Article  CAS  PubMed  Google Scholar 

  • Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122(5):509–22.

    Article  CAS  PubMed  Google Scholar 

  • Schnydrig S, Korner L, Landweer S, Ernst B, Walker G, Otten U, Kunz D. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett. 2007;429(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  • Schroeder M, Krebs MO, Bleich S, Frieling H. Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry. 2010;23(6):588–92.

    Article  PubMed  Google Scholar 

  • Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE. S100B is increased in mood disorders and may be reduced by antidepressive treatment. NeuroReport. 2002;13(13):1675–8.

    Article  CAS  PubMed  Google Scholar 

  • Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 1992;55(6):621–6.

    Article  CAS  PubMed  Google Scholar 

  • Segi-Nishida E, Warner-Schmidt JL, Duman RS. Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A. 2008;105(32):11352–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shen Q, Lal R, Luellen BA, Earnheart JC, Andrews AM, Luscher B. Gamma-and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry. 2010;68(6):512–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sokolov BP. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol. 2007;10(4):547–55.

    Article  CAS  PubMed  Google Scholar 

  • Stahl SM, Lee-Zimmerman C, Cartwright S, Morrissette DA. Serotonergic drugs for depression and beyond. Curr Drug Targets. 2013;14(5):578–85.

    Article  CAS  PubMed  Google Scholar 

  • Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharmacol. 2013;23(10):1199–1207.

    Google Scholar 

  • Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 2004;56(9):640–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stranahan AM, Khalil D, Gould E. Social isolation delays the positive effects of running on adult neurogenesis. Nat Neurosci. 2006;9(4):526–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun JD, Liu Y, Yuan YH, Li J, Chen NH. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology. 2012;37(5):1305–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology. 2013;38(1):124–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362(9386):798–805.

    Article  CAS  PubMed  Google Scholar 

  • Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4(1):13–25.

    Article  CAS  PubMed  Google Scholar 

  • Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol. 1990;185(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  • Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006;9(4):519–25.

    Article  CAS  PubMed  Google Scholar 

  • Uher R, Payne JL, Pavlova B, Perlis RH. Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety. 2014;31:459–71.

    Article  PubMed  Google Scholar 

  • Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67(2-3):269–75.

    Article  PubMed  Google Scholar 

  • Varghese BAFP, Brown ES. The hypothalamic-pituitary-adrenal axis in major depressive disorder: a brief primer for primary care physicians. Prim Care Companion J Clin Psychiatry. 2001;3(4):151–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vialou V, Feng J, Robison AJ, Nestler EJ. Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol. 2013;53:59–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev. 1990;14(1):49–63.

    Article  CAS  PubMed  Google Scholar 

  • Wagner-Smith K, Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into chronic neuroinflammatory condition? Neurosci Biobehav Rev. 2011;35:742–64.

    Article  Google Scholar 

  • Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A. 2007;104(11):4647–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Watanabe K, Hashimoto E, Ukai W, Ishii T, Yoshinaga T, Ono T, Tateno M, Watanabe I, Shirasaka T, Saito S, Saito T. Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1450–4.

    Article  CAS  PubMed  Google Scholar 

  • Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol. 2002;5:375–88.

    Article  CAS  PubMed  Google Scholar 

  • Wichniak A, Riemann D, Kiemen A, Voderholzer U, Jernajczyk W. Comparison between eye movement latency and REM sleep parameters in major depression. Eur Arch Psychiatry Clin Neurosci. 2000;250(1):48–52.

    Article  CAS  PubMed  Google Scholar 

  • Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP. Depression, sleep physiology, and antidepressant drugs. Depress Anxiety. 2001;14(1):19–28.

    Article  CAS  PubMed  Google Scholar 

  • Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol. 2006;21 Suppl 1:S11–5.

    Article  PubMed  Google Scholar 

  • Wirz-Justice A. Biological rhythms and depression: treatment opportunities. WPA Bull Depress. 2008;12:5–8.

    Google Scholar 

  • World Health Organization. The global burden of disease. 2004 Update. Geneva: WHO; 2008.

    Google Scholar 

  • World Health Organization. Depression. Fact sheet N°369; 2015.

    Google Scholar 

  • Yamada K, Watanabe A, Iwayama-Shigeno Y, Yoshikawa T. Evidence of association between gamma-aminobutyric acid type A receptor genes located on 5q34 and female patients with mood disorders. Neurosci Lett. 2003;349(1):9–12.

    Article  CAS  PubMed  Google Scholar 

  • Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry. 2003;60(1):24–8.

    Article  CAS  PubMed  Google Scholar 

  • Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856–64.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was financed through project UID/QUI/50006/2013, receiving financial support from FCT/MEC through national funds, and co-financed by FEDER, under the Partnership Agreement PT2020. To all financing sources the authors are greatly indebted. Clara Grosso thanks FCT for the FCT Investigator (IF/01332/2014).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula B. Andrade .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Grosso, C., Valentão, P., Andrade, P.B. (2016). Depressive Disorders: Prevalence, Costs, and Theories. In: Grosso, C. (eds) Herbal Medicine in Depression. Springer, Cham. https://doi.org/10.1007/978-3-319-14021-6_1

Download citation

Publish with us

Policies and ethics